Vicore Pharma AB’s Post

Healthcare x AI = Precision medicine Olga Troyanskaya, Professor of computer science at Princeton University, discussed with Vijay Pande, PhD the pivotal role of integrating artificial intelligence with genomics to advance precision medicine. The burgeoning field of AI and machine learning has the potential to sift through vast genomic data, identifying critical disease markers and aiding in the development of targeted therapies. As technologies evolve, the capability to capture a holistic view of cellular functions at a granular level is becoming easier, which is indispensable for drug discovery and treatment development. The transformative power of marrying AI with genomics heralds a new era of precision medicine that could significantly enhance healthcare outcomes. Listen to the full conversation between two tech optimists, Vijay and Olga, on Bio Eats World: https://lnkd.in/gHFup-RB

I am lucky enough to work with some of the smartest people in the world. Read on to learn more about how we're rethinking facilities to account for personalized medicine and how AI is showing up in our work! From the increased focus on patient-centric care to the increased adoption of artificial intelligence and machine learning, CRB experts are sharing their insights and expertise. Noel Maestre recently spent time with Pharma’s Almanac to discuss how patient-centric care is influencing our work at CRB. In a separate roundtable with the same publication, Ryan shares what areas of pharma and biopharma see the most opportunity with AI and machine learning. Read more from our experts at the link below. #LifeSciences #PatientCentric #Biopharma #Industry40

From the increased focus on patient-centric care to the increased adoption of artificial intelligence and machine learning, CRB experts are sharing their insights and expertise. Noel Maestre recently spent time with Pharma’s Almanac to discuss how patient-centric care is influencing our work at CRB. In a separate roundtable with the same publication, Ryan shares what areas of pharma and biopharma see the most opportunity with AI and machine learning. Read more from our experts at the link below. #LifeSciences #PatientCentric #Biopharma #Industry40

From the increased focus on patient-centric care to the increased adoption of artificial intelligence and machine learning, CRB experts are sharing their insights and expertise. Noel Maestre recently spent time with Pharma’s Almanac to discuss how patient-centric care is influencing our work at CRB. In a separate roundtable with the same publication, Ryan shares what areas of pharma and biopharma see the most opportunity with AI and machine learning. Read more from our experts at the link below. #LifeSciences #PatientCentric #Biopharma #Industry40

From the increased focus on patient-centric care to the increased adoption of artificial intelligence and machine learning, CRB experts are sharing their insights and expertise. Noel Maestre recently spent time with Pharma’s Almanac to discuss how patient-centric care is influencing our work at CRB. In a separate roundtable with the same publication, Ryan shares what areas of pharma and biopharma see the most opportunity with AI and machine learning. Read more from our experts at the link below. #LifeSciences #PatientCentric #Biopharma #Industry40

From the increased focus on patient-centric care to the increased adoption of artificial intelligence and machine learning, CRB experts are sharing their insights and expertise. Noel Maestre recently spent time with Pharma’s Almanac to discuss how patient-centric care is influencing our work at CRB. In a separate roundtable with the same publication, Ryan shares what areas of pharma and biopharma see the most opportunity with AI and machine learning. Read more from our experts at the link below. #LifeSciences #PatientCentric #Biopharma #Industry40

From the increased focus on patient-centric care to the increased adoption of artificial intelligence and machine learning, CRB experts are sharing their insights and expertise. Noel Maestre recently spent time with Pharma’s Almanac to discuss how patient-centric care is influencing our work at CRB. In a separate roundtable with the same publication, Ryan shares what areas of pharma and biopharma see the most opportunity with AI and machine learning. Read more from our experts at the link below. #LifeSciences #PatientCentric #Biopharma #Industry40

From the increased focus on patient-centric care to the increased adoption of artificial intelligence and machine learning, CRB experts are sharing their insights and expertise. Noel Maestre recently spent time with Pharma’s Almanac to discuss how patient-centric care is influencing our work at CRB. In a separate roundtable with the same publication, Ryan shares what areas of pharma and biopharma see the most opportunity with AI and machine learning. Read more from our experts at the link below. #LifeSciences #PatientCentric #Biopharma #Industry40

From the increased focus on patient-centric care to the increased adoption of artificial intelligence and machine learning, CRB experts are sharing their insights and expertise. Noel Maestre recently spent time with Pharma’s Almanac to discuss how patient-centric care is influencing our work at CRB. In a separate roundtable with the same publication, Ryan shares what areas of pharma and biopharma see the most opportunity with AI and machine learning. Read more from our experts at the link below. #LifeSciences #PatientCentric #Biopharma #Industry40

From the increased focus on patient-centric care to the increased adoption of artificial intelligence and machine learning, CRB experts are sharing their insights and expertise. Noel Maestre recently spent time with Pharma’s Almanac to discuss how patient-centric care is influencing our work at CRB. In a separate roundtable with the same publication, Ryan shares what areas of pharma and biopharma see the most opportunity with AI and machine learning. Read more from our experts at the link below. #LifeSciences #PatientCentric #Biopharma #Industry40